New RNA therapy aims to tame Out-of-Control immune system

This early-stage study tests a new treatment called RXIM002 for people with severe autoimmune diseases that haven't responded to standard therapies. The treatment uses a special RNA molecule to create immune cells that target and destroy faulty B cells, which are causing the disease. The main goals are to check if the treatment is safe and to see how long the modified cells stay in the body. About 27 adults aged 18 to 65 with conditions like lupus are being enrolled.